Relmada Therapeutics (RLMD) Property, Plant & Equipment (Net) (2013 - 2021)
Powered by 
Analysis
Relmada Therapeutics (RLMD) Property, Plant & Equipment (Net) (2013 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.67 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 5.46 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 2.06 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 34.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.64 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 554.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 107.22 Mn |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 452.00 |
| Dec 31, 2020 | 1,258.00 |
| Sep 30, 2020 | 2,081.00 |
| Jun 30, 2020 | 2,935.00 |
| Mar 31, 2020 | 3,964.00 |
| Dec 31, 2019 | 5,010.00 |
| Sep 30, 2019 | 6,110.00 |
| Jun 30, 2019 | 7,210.00 |
| Mar 31, 2019 | 8,298.00 |
| Dec 31, 2018 | 9,374.00 |
| Sep 30, 2018 | 10,676.00 |
| Jun 30, 2018 | 12,080.00 |
| Mar 31, 2018 | 3,208.00 |
| Dec 31, 2017 | 3,776.00 |
| Sep 30, 2017 | 4,358.00 |
| Jun 30, 2017 | 2,315.00 |
| Mar 31, 2017 | 511,824.00 |
| Dec 31, 2016 | 514,865.00 |
| Sep 30, 2016 | 536,012.00 |
| Jun 30, 2016 | 531,348.00 |